Case Analysis of the Participation of Clinical Pharmacist in Antifungal Drug Treatment of New Type Crypto-coccal Meningitis
10.6039/j.issn.1001-0408.2015.20.41
- VernacularTitle:临床药师参与1例新型隐球菌性脑膜炎抗真菌治疗的病例分析
- Author:
Wenxu SUN
;
Ting XU
- Publication Type:Journal Article
- Keywords:
Clinical pharmacist;
New type cryptococcal meningitis;
Antifungal drugs;
Pharmaceutical care
- From:
China Pharmacy
2015;(20):2854-2857
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the method of pharmaceutical care for antifungal drug treatment of new type crypto-coccal meningitis by clinical pharmacist. METHODS:Clinical pharmacist participated in the drug treatment process for a pa-tient with new type cryptococcal meningitis. Clinical pharmacist provided pharmaceutical care in following aspects:assisting doctor to optimize antifungal drugs treatment plan,providing patients pharmaceutical monitoring and medication education, etc. During amphotericin B treatment,the patient developed refractory hypokalemia. Clinical pharmacists suggested doctors to reduce the dose of amphotericin B and additionally use voriconazole for antifungal treatment. RESULTS:The patient devel-oped refractory hypokalemia no more after the plan was adjusted. After 11 weeks of systematic antifungal treatment,the pa-tient was on the mend. CONCLUSIONS:The participation of clinical pharmacist in antifungal treatment of new type cryptococ-cal meningitis indicates that following the instructions,but not lost flexible disposal;providing service actively,and details is guarantee of safety.
